# Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies

> **NCT00890955** · PHASE1 · COMPLETED · sponsor: **Lawrence Einhorn** · enrollment: 36 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** Amrubicin
- **DRUG:** Cyclophosphamide

## Key facts

- **NCT ID:** NCT00890955
- **Lead sponsor:** Lawrence Einhorn
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2015-12-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00890955

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00890955, "Amrubicin + Cyclophosphamide in Advanced Solid Organ Malignancies". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00890955. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*